The startup develops a healthy longevity platform that utilizes single-cell genomics and transcriptomics to provide aging diagnostics and therapeutic insights. By generating detailed diagnostic reports for clinics, the platform identifies potential drug repurposing candidates and enhances quality control in cell therapy.
Funding
$650K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current aging diagnostics and therapeutic development lack the precision needed for individualized treatment strategies. Traditional methods do not fully integrate the complexities of somatic genotype with cellular phenotype at the single-cell level, hindering the development of targeted interventions. Existing approaches often fail to provide detailed insights into the aging process at a cellular level, limiting the ability to identify effective drug repurposing candidates and optimize cell therapies.
Solution
AgeCurve is developing an AI-driven multiomics platform that integrates somatic genotype with cellular phenotype at the single-cell level to create advanced aging diagnostics and therapeutics tools. The platform employs a machine learning and AI stack to decode the aging process cell by cell, enabling precision drug optimization at the individual level. By generating detailed diagnostic reports, AgeCurve aims to provide clinicians with insights into potential drug repurposing candidates and enhance quality control in cell therapy. The platform's approach allows for a more individualized and targeted approach to aging therapeutics, moving beyond traditional methods.
Target Audience
The primary target audience includes clinicians and researchers focused on aging and longevity, as well as pharmaceutical companies and cell therapy developers seeking to improve the efficacy and precision of their treatments.
Features
- Single-cell level analysis combining somatic genotype with cellular phenotype
- AI-driven platform for decoding the aging process
- Machine learning stack for precision drug optimization
- Diagnostic reports for identifying potential drug repurposing candidates
- Tools for enhancing quality control in cell therapy